800 Participants Needed

Prostate Cancer Screening Education for Prostate Cancer

ET
Overseen ByErika Trapl, PhD
Age: 18+
Sex: Male
Trial Phase: Academic
Sponsor: Case Comprehensive Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to identify the best methods to encourage and support Black or African American men, aged 40 and older, in completing prostate cancer screening, particularly the prostate-specific antigen (PSA) test. The trial evaluates three educational approaches: one involves community events with a navigator to guide participants (Education at Community Outreach Screening Event); another includes only the navigator (Education by Community Navigator); and the third uses barber-led education with online resources. Black or African American men who have not had a PSA test in the last year may be suitable candidates. This research seeks to improve prostate cancer screening rates in this community. As an unphased trial, the study offers a unique opportunity to contribute to important research that could enhance health outcomes in the community.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that these intervention strategies are safe?

Research has shown that educational programs for prostate cancer screening are generally safe for participants. These programs aim to provide information and encourage screening without introducing new medical treatments or drugs.

In studies where education and guidance were used, participants reported no negative effects from the education itself. For example, community outreach programs, which include education and support, commonly help people understand their health choices. These programs have successfully increased screening rates without causing harm.

One study found that educational efforts significantly increased PSA testing, a standard blood test for prostate cancer screening. This suggests that these programs are well-received and can safely raise awareness and promote health screenings.

Overall, educational programs in these settings have proven safe, as they provide guidance and support rather than medical procedures or drugs.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores innovative ways to educate men about prostate cancer screening through community-based methods. Unlike traditional awareness campaigns that might rely on pamphlets or online ads, this trial uses community navigators and events at familiar locations like barber shops to deliver information in a more personal and engaging way. The approach aims to make screening more accessible and relatable by providing direct support and resources in places where men already feel comfortable. By potentially increasing awareness and motivation to get screened, this method could lead to earlier detection of prostate cancer, improving outcomes for those at risk.

What evidence suggests that this trial's education strategies could be effective for encouraging prostate cancer screening?

Research has shown that community-based screening programs can help overcome obstacles to prostate cancer screening. In this trial, the Education and Active Navigation with Community-Based Outreach arm includes the Education at Community Outreach Screening Event. Studies have found that this approach can improve health knowledge and encourage screening among participants. The Education and Active Navigation arm features Education by Community Navigator. Evidence indicates that community navigators can assist Black men in discussing their prostate cancer risk with a doctor, leading to better health outcomes. Lastly, the Education and Passive Navigation arm involves Passive Education, which has been shown to increase understanding of cancer risk reduction, encouraging more men to get screened. Overall, these educational strategies in the trial can boost prostate cancer screening rates by raising awareness and addressing specific community needs.12678

Who Is on the Research Team?

ET

Erika Trapl, PhD

Principal Investigator

Case Comprehensive Cancer Center

Are You a Good Fit for This Trial?

This trial is for Black or African American individuals who are 40 years old or older, have a prostate gland, and haven't had a PSA test in the last year. They must be able to consent to the study and speak English. Those who've had their prostate removed can't join.

Inclusion Criteria

Self-identify as Black or African American
English speaking
I have never had a PSA test or it's been over a year since my last one.
See 3 more

Exclusion Criteria

I have had surgery to remove my prostate.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Recruitment and Intervention

Participants are recruited and receive one of three intervention strategies: education and passive navigation, education and active navigation, or education and active navigation with community-based outreach.

4 months
Community-based visits and outreach events

Follow-up

Participants are monitored for PSA test completion and provide feedback on their screening experience.

4 months
1 follow-up visit (in-person or virtual)

Long-term Follow-up

Participants are encouraged to follow up with a primary care physician for routine care.

10 months

What Are the Treatments Tested in This Trial?

Interventions

  • Education at Community Outreach Screening Event
  • Education by Community Navigator
  • Passive Education
Trial Overview The study tests different ways of educating about prostate cancer screening: one-on-one guidance from community navigators, education at community events, and passive educational materials. The goal is to see if these methods increase PSA testing rates.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Group I: Education and Passive NavigationExperimental Treatment1 Intervention
Group II: Education and Active Navigation with Community Based OutreachExperimental Treatment3 Interventions
Group III: Education and Active NavigationExperimental Treatment2 Interventions

Education at Community Outreach Screening Event is already approved in United States for the following indications:

🇺🇸
Approved in United States as Community Outreach Screening Event for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Case Comprehensive Cancer Center

Lead Sponsor

Trials
472
Recruited
33,400+

Published Research Related to This Trial

A public seminar on prostate cancer organized by a committee of healthcare professionals revealed a strong demand for education and support among attendees, indicating a gap in current resources for patients and caregivers.
Feedback from participants highlighted a significant interest in ongoing support groups and additional educational forums, suggesting that such initiatives could greatly benefit those affected by prostate cancer.
Prostate disease patients: planning services to meet their coping needs.Anderson, PJ., Dowell, CJ., Fairbrother, G., et al.[2015]
A quasi-experimental study involving 448 male employees showed a significant improvement in knowledge and attitudes towards prostate and testicular cancer after an educational program, with a mean score increase of 23.4% (p < 0.01).
The success of this educational initiative has led to broader statewide efforts to enhance awareness and education about prostate cancer, which is increasingly important given its rising incidence among men.
Male cancer awareness: impact of an employee education program.Martin, JP.[2015]
A review of educational intervention trials in prostate cancer over the last 10 years revealed that most studies focused on managing the disease, treatments, and side effects, highlighting the importance of education in patient care.
Understanding psychosocial stressors and educational interventions is essential for nurses, as these factors significantly impact the well-being of men with prostate cancer and their families.
Psychosocial and educational intervention trials in prostate cancer.Germino, BB.[2019]

Citations

Cancer health awareness through screening and educationLoss of sexual function is a possible side effect of prostate cancer, 83, 78. Problems with urination are possible side effects of prostate ...
Connect2Care: Prostate Cancer Education and Screenings ...The primary goal of this study is to evaluate the efficacy of the Connect2Care App in a 30-day randomized control trial compared to an existing app developed by ...
Evaluating the impact of a community-based prostate ...Community based screening programs may be an effective way to overcome barriers to prostate cancer screening.
Prostate Cancer: Community Education and Disparities in ...This article addresses barriers in screening, diagnosis, treatment, and community education that contribute to the disparate burden of prostate cancer among ...
The Utility of Contemporary Community-Based Prostate ...The success of community-based PCa early detection campaigns has been previously shown to improve health education and PCa screening behavior.9 This study aims ...
6.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/38673327/
A Community-Based Prostate Cancer Screening and ...This study analyzed data from a community-based prostate cancer (PCa) education and screening program (Prostate Outreach Project; POP) to enhance PCa-related ...
Prostate Cancer Screening Education for Prostate CancerIs the prostate cancer screening education program safe for humans? The research articles reviewed do not provide specific safety data for the prostate cancer ...
Cancer Community Outreach | Mount Sinai - New YorkCancer Community Outreach 2018 goals are to ensure that outreach programs and efforts for screening and early detection of cancer, cancer-related risk and ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security